Sunways India Pvt Ltd. More Than 60 Years of Dedicated & Commited Effort in the Field of OPTHAMOLOGY
OFLO DM - Ofloxacin 0.3% + Dexamethasone 0.1% Eye Drops
OFLO DM  
Composition w/v  
Ofloxacin USP 0.3% w/v
Dexamethasone Sodium Phosphate I.P.  
as Dexamethasone Phosphate 0.1% w/v
Benzalkonium Chloride Solution I.P.  
Equivalent to Benzalkonium Chloride 0.01% w/v
Sterile Aqueous Vehicle q.s.
Dosage form
Eye Drops - Ophthalmic Solution
Category
Antibiotic + Steroid
Indications
Oflo-Dm Eye Drops is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial ocular infection or a risk of bacterial ocular infection exists.
Dosage
One or two drops instilled into the conjunctival sacs every four to six hours.
Contraindications
Oflo dm is contraindicated in patients with a history of hypersensitivity to ofloxacin or other quinolones and dexamethasone or other steroids or any of the components present in the formulation.
Epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and in many other viral diseases of the conjunctiva and cornea, mycobacterial infection of the eye, fungal diseases of ocular structures.
Special Precautions
Prolonged use may result in overgrowth of non susceptible bacteria, including fungi. If super infection occurs and clinical improvement is not noticed in 7 days, the use of oflo dm must be discontinued and appropriate therapy should be initiated.
Pregnancy
Safety of the use of oflo dm in pregnancy has not been established, there are no adequate studies in pregnant women. It should be used with caution only if the potential benefit justifies the risks to the foetus.
Adverse Effects
Transient ocular burning or discomfort, stinging, itching, redness, tearing, and dryness may occur.
Storage
Store in a cool dry place. Protect from light.
Presentation
OFLO-DM Eye drops is available in sterile FFS pack.Of 10 ml.